Sanofi uses GS1 standards in clinical trials for significant operational and human health benefits
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Body
The global biopharmaceutical company wanted to improve the efficiency of its operational processes related to investigational products that, in turn, would deliver numerous benefits for its healthcare providers and patients.
Sanofi worked with its supply chain stakeholders to transition from the use of multiple proprietary barcodes to global GS1 standards. Today, investigational products are uniquely identified with GS1 Global Trade Item Numbers (GTINs) encoded in GS1 DataMatrix barcodes. This standardised approach helps Sanofi’s hospitals and trial sites better manage clinical trial activities so that the right investigational product and/or kit goes to the right patient.
File
